"Cadence(R) Virus Inactivation System" enables automatic pH adjustment without relying on operator skill.
This is a virus inactivation system suitable for continuous and batch processes. It accommodates scales from small-scale to commercial production scales of 2,000 L. (※Conditions for compatibility need to be confirmed.) To minimize the operator's burden, it is a fully automated system capable of continuously performing low pH virus inactivation treatment. Additionally, it is possible to record the data for pH adjustments. Depending on the application, one or two Allegro(TM) single-use mixers (sold separately) can be connected. A mixing system and recirculation loop are employed to synchronize them to function alternately, allowing one system to perform virus inactivation under low pH conditions while the other collects and retains the process liquid.
Inquire About This Product
basic information
【Functions and Configuration】 ■ Continuous processing through complete automation ■ Software compatible with both batch mode and continuous mode ■ The liquid inlet is mounted on the side of the mixer, making it less likely to produce foaming or splashing during transfer, titration, and mixing ■ Capable of processing elution liquid at a speed of up to 30L/h
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
